Sternschuss, M., Whiting, K., Yol, C., Arbuiso, A., Gupta, A., Bent, E. H., Basar, M., Regazzi, A. M., Liang, S., Ahmed, F., Beylergil, V., Akin, O., Funt, S. A., Niglio, S. A., Lage, D. E., Iyer, G., Al-Ahmadie, H., Rosenberg, J. E., Ostrovnaya, I., Aggen, D. H. (2026). Membranous and cytoplasmic Nectin4 expression and outcomes with enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.801